L-Mesitran

L-Mesitran is a biomedical company based in Maastricht, the Netherlands, specializing in Medical Grade Honey (MGH)-based wound care products. Founded in July 2000, the company emerged from Dr. Theo Postmes's research at the University Hospital of Maastricht, which highlighted honey's effectiveness in promoting wound healing. L-Mesitran was the first to receive CE certification and FDA approval for a honey-based medical device in Europe in 2002. The company offers a range of wound care solutions, including L-Mesitran Soft, a honey-based wound gel, and L-Mesitran Foam, a hydrophilic foam dressing. These products are designed to enhance healing by maintaining moisture, stimulating tissue growth, and providing antibacterial properties. L-Mesitran's products are used in over 60 countries, serving both hospital and home care settings, and are effective for various wound types, including those with antibiotic-resistant pathogens. The company is committed to ongoing research to enhance its offerings and maintain its position as a leader in honey-based wound care.

• Employees13
• Founded2000